AlphaYouNL
Insider selling
Nathan L. Mata sold $102K of Belite Bio, Inc (BLTE) stock
Nathan L. Mata, Chief Scientific Officer of Belite Bio, Inc (BLTE), sold 666 shares of BLTE stock worth $102K, per an SEC Form 4 filed May 8, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on May 7, 2026, 1 day before it was made public.
BLTE has moved +11.2% since the trade date, from $156.00 to $173.40 (Sep 21, 2026 close).
- Traded
- May 7, 2026
- Disclosed
- May 8, 2026
- Filing delay
- 1 day
- Price since
- +11.2%
- Role
- Chief Scientific Officer
- Source
- SEC Form 4
More BLTE insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.